Please login to the form below
Mallinckrodt
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Mallinckrodt's Japan sales performance.
Deal Watch January 2018
Patent settlement, non-exclusive licence. 200. Mallinckrodt/Baxter International. RECOTHROM® Thrombin topical and PREVELEAK® Surgical Sealant to control bleeding in surgery.
Mallinckrodt pays $1.2bn for Sucampo Pharma
Mallinckrodt pays $1.2bn for Sucampo Pharma. The Irish group will acquire Amitizia, Rescula and a pipeline of rare disease projects. ... As 2017 drew to a close, Mallinckrodt signed a deal to buy Sucampo Pharma of the US - and its constipation drug
Pharma deals continue to slide
products. While this may not have been the reason behind GSK’s termination of its rare disease projects, it has not deterred Mallinckrodt from acquiring Infacare, a US company with a ... 469 (upfront 31). Infacare (US). Mallinckrodt (US/GB). Company
Deal Watch August 2016
Mallinckrodt (US) Nuclear Imaging business. IBA Molecular (BE). Asset acquisition. Diagnostic imaging products for use in nuclear medicine including molybdenum-99.
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Featured jobs
- Strategic Planner, Healthcare Advertising
-
£47, 000 – £53, 000
- Account Director, Medical Communications
-
C£50 – 65, 000 benefits and bonus
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
- Account Director, Training & Medical Communications, London
-
Competitive Salary
- Senior Medical Writer, MedComms Agency
-
£40 - 55, 000 according to skills and experience benefits
- Science Writer – Healthcare Advertising
-
Salary TBC
- Senior Strategic Planner, Healthcare Brand Communications, Londo...
-
Competitive Salary
- Multi-Channel Account Managers - Road / Home-office based – Full...
-
Competitive salary
- Medical Writer, Healthcare Advertising
-
£35 - £45, 000 benefits
- Senior Account Director or Business Unit Director, Healthcare Ad...
-
C£60, 000 – £70, 000 benefits
-
Scientific Engagement Director
-
Salary will be dependant on experience
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
- Medical Writer - Medical Communications
-
£30, 000 - £40, 000 according to skills and experience plus benefits
-
Account Manager
-
£40, 000 - £45, 000 benefits
Subscribe to our email news alerts
- Roche starts new late-stage trials of Alzheimer’s candidate
- AbbVie, Roche get FDA OK for broader use of Venclexta
- Moving annual total (MAT)
- UK pharma cheers EU science announcement
- AbbVie builds case for arthritis blockbuster-in-waiting upadacitinib
- Daily Brief: Tagrisso's first line approval, EULAR and EHA, and why Stephen Hawking was wrong on NHS
- NICE set to reject Kyowa Kirin’s Crysvita for XLH
- More impressive data from Bluebird’s gene therapy in thalassemia and sickle cell disease
- UK firm Nightstar bags FDA fast-track status for gene therapy
- British Business Bank sets up £2.5bn fund for ‘unicorn’ firms
- Commentary: Roseanne’s racist tweet and Sanofi’s swift and surprising riposte
- Anthill Agency launch digital-focused academy
PMHub
WCG
WCG is an independent, global agency specialising in healthcare communications. Our value as a company is about being the positive...
Latest intelligence
- Australian Flu and the dilemma of naming diseases
- ...
- Wearables and Healthcare
- What place do wearables have in affecting actual patient health outcomes and can they contribute to the NHS’s sustainability agenda? Or are they just the latest fad?...
- What does a future-proof rep look like?
- Businesses can no longer afford to push ahead with the traditional Key Account Management model....
Quick links
Infographics
